BIM-018

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
BIM-018
BIM-018 structure.png
Legal status
Legal status
Identifiers
ChemSpider
Chemical and physical data
FormulaC23H22N2O
Molar mass342.4 g/mol g·mol−1
3D model (JSmol)

BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB2 receptor and has been sold online as a designer drug.[1]

Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor.[2]

See also[edit]

References[edit]

  1. ^ "BIM-018". Cayman Chemical. Retrieved 24 July 2015.
  2. ^ Daniel Pagé; Elise Balaux; Luc Boisvert; Ziping Liu; Claire Milburn; Maxime Tremblay; Zhongyong Wei; Simon Woo; Xuehong Luo; Yun-Xing Cheng; Hua Yang; Sanjay Srivastava; Fei Zhou; William Brown; Miroslaw Tomaszewski; Christopher Walpole; Leila Hodzic; Stéphane St-Onge; Claude Godbout; Dominic Salois; Keymal Payza (July 2008). "Novel benzimidazole derivatives as selective CB2 agonists". Bioorganic & Medicinal Chemistry Letters. 18 (13): 3695–3700. doi:10.1016/j.bmcl.2008.05.073. PMID 18522867.